Behnam N Tehrani, MD

Dr. Behnam Tehrani is a specialty care physician board certified in interventional cardiology and cardiovascular disease. He joined Inova Medical Group with several years of clinical experience. He serves as the Co-Director of Cardiac Catheterization Laboratories for Inova Fairfax Medical Campus and Co-Director of the Inova Heart and Vascular Institute’s Complex Coronary Therapeutics and Cardiogenic Shock Programs. Dr. Tehrani's clinical expertise is in the management of complex coronary and peripheral vascular disease. Dr. Tehrani is a member of Inova’s cardiogenic shock, coronary chronic total occlusion, pulmonary embolism and chronic thromboembolic pulmonary hypertension programs. He also serves on national committees with the American College of Cardiology and the Society for Cardiovascular Angiography and Intervention. He has been an investigator in clinical trials for coronary artery disease, cardiogenic shock and pulmonary embolism management.   Dr. Tehrani became interested in interventional cardiology because of the opportunity to use catheter-based technologies and evidence based-medicine to work with the collaborative heart team and provide care to acute and chronically ill patients with cardiovascular disease. A native of Potomac, MD, Dr. Tehrani resides in Northern Virginia. In his spare team, he enjoys spending time with his family, exercising and traveling. Awards/Associations/Appointments Top Doctors, Washingtonian, 2020-2022 Blog Posts Improving Outcomes with a Regionalized Systems of Care For Cardiogenic Shock Treatment (November 2022) Surviving Cardiogenic Shock: Survival Rates Soar at Inova (April 2019) Publications A Standardized and Regionalized Network of Care for Cardiogenic Shock, JACC: Heart Failure Standardized Team-Based Care for Cardiogenic Shock, Journal of American College of Cardiology (Vol. 73, No. 13, 2019) Podcasts, Webcasts and Videos How Heart Disease Differs for Men and Women (February 2022) Inova Health Talk: What You Should Know About Cardiovascular Disease (February 2020)